RioTech Pharmaceuticals

company

About

RioTech is an information site about Hepatitis C and the many forms of treatment and medication avaliable to those who suffer from it.

  • 1 - 10

Details

Last Funding Type
Seed
Last Funding Money Raised
£250K
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2003
Number Of Employee
1 - 10
Operating Status
Active

RioTech is an information site about Hepatitis C and the many forms of treatment and medication avaliable to those who suffer from it. Pharmasutical companies and reserchers from Oxford to California and all over the world are working to find better ways of treating and overcoming this virus. As it stands now, there is no here is no vaccine available to prevent HCV, and treatment for the stronger strain of the virus is only effective in treating it 50% of the time. However for those who are infected, there is some hope. Reserchers in the field of HCV treatment are beginging to understand more and more about Hepatitis C, and how to treat it. This website aims to relay this message to as many people as possible.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
£250K
RioTech Pharmaceuticals has raised a total of £250K in funding over 2 rounds. Their latest funding was raised on Aug 1, 2003 from a Seed round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 1, 2003 Seed £250K 1 University Challenge Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
1
RioTech Pharmaceuticals is funded by 1 investors. University Challenge Fund are the most recent investors.
Investor Name Lead Investor Funding Round
University Challenge Fund Yes Seed